Extracorporeal Membrane Oxygenation-Assisted Percutaneous Coronary Intervention in Extremely High-Risk Patients  

作　　者：Wen-Jian Shi Yu-Xuan Zhang Gui-Ping Xu Qing-Jun Ma Jian-Hua Qin Xin-Hua Wu Li Wang 

机构地区：[1]Department of Anesthesia, People's Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang 830001, China

出　　处：《Chinese Medical Journal》2018年第13期1625-1627,共3页中华医学杂志（英文版）

基　　金：This study was supported by a grant from the National Natural Science Foundation of China （No. 81160016）.

摘　　要：To the Editor： High-risk percutaneous coronary intervention （PCI） remains a viable revascularization strategy for patients who refuse or are not suitable for surgery, Extracorporeal membrane oxygenation （ECMO） can direct blood flow from the body, oxygenate it, and then return it, thus completely or partially replacing the function of the heart and lungs and increasing the likelihood of functional recovery. Selective PCI supported by ECMO is a viable alternative for patients who are at very high risk for coronary artery bypass gratting （CABG）. A previous study found that ECMO-assistcd PCI for patients with acute myocardial infarction complicated by profound cardiogenic shock might have improved 30-day and l-year survival rates, and we believe that ECMO is a viable mode of hemodynamic support in high-risk cases.To the Editor： High-risk percutaneous coronary intervention （PCI） remains a viable revascularization strategy for patients who refuse or are not suitable for surgery, Extracorporeal membrane oxygenation （ECMO） can direct blood flow from the body, oxygenate it, and then return it, thus completely or partially replacing the function of the heart and lungs and increasing the likelihood of functional recovery. Selective PCI supported by ECMO is a viable alternative for patients who are at very high risk for coronary artery bypass gratting （CABG）. A previous study found that ECMO-assistcd PCI for patients with acute myocardial infarction complicated by profound cardiogenic shock might have improved 30-day and l-year survival rates, and we believe that ECMO is a viable mode of hemodynamic support in high-risk cases.

分 类 号：R614[医药卫生—麻醉学]